silver has been researched along with Pseudomonas Infections in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (35.29) | 18.7374 |
| 1990's | 4 (5.88) | 18.2507 |
| 2000's | 2 (2.94) | 29.6817 |
| 2010's | 26 (38.24) | 24.3611 |
| 2020's | 12 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Armijo, LM; Brandt, YI; Cook, NC; Huber, DL; Kopciuch, M; Monson, TC; Osiński, M; Rivera, AC; Smyth, HDC; Wawrzyniec, SJ; Withers, NJ | 1 |
| de Souza, A; Hamood, AN; Huynh, E; Mehta, D; Moeller, CD; Moeller, KW; Morgan, M; Reid, TW; Tran, PL | 1 |
| Dhandapani, R; Muthupandian, S; Palanivel, V; Paramasivam, R; Rahuman, HBH; Thangavelu, S | 1 |
| Mackie, I; Nour, S; Reid, G; Sathanantham, K | 1 |
| Ali, D; Arunachalam, K; Balusamy, SR; Gurusamy, A; Kathirason, SG; Sellami, H; Shanmugam, R; Subramaniam, R | 1 |
| Campo-Beleño, C; Coria-Jimenez, R; Fernández-Presas, AM; Franco, B; Franco-Cendejas, R; García-Contreras, R; González, EE; Hernández-Durán, M; Jiménez-García, LF; Lara-Martínez, R; López-Jácome, LE; Morales-Espinosa, R; Muñoz-Carranza, S; Villamizar-Gallardo, RA | 1 |
| Desai, TA; Finbloom, JA; Kharbikar, BN; Kwon, M; Raghavan, P; Yu, MA | 1 |
| Ahmed, ZS; Awad, FH; Cheang, T; Li, X; Marouf, S; Nader, SM; Salem, HM; Shaalan, M; Zhou, H | 1 |
| Giri, VP; Katiyar, R; Kumari, M; Mishra, A; Nautiyal, CS; Pandey, S; Paswan, SK; Rao, CV; Srivastava, M; Tripathi, A | 1 |
| Banks, CE; Butler, JA; El Mohtadi, M; Karaky, N; Kirby, A; McBain, AJ; Whitehead, KA | 1 |
| Day, D; Soundy, J | 1 |
| Dube, P; Madiehe, A; Meyer, M; Meyer, S | 1 |
| Almqvist, S; Gerner, E; Thomsen, P; Trobos, M; Werthén, M | 1 |
| Ahmad, I; Ejaz, H; Muzammil, S; Qamar, MU; Qureshi, R; Rasool, MH; Shafique, M | 1 |
| Kasithevar, M; Mohan, M; Muthupandian, S; Periakaruppan, P | 1 |
| Dai, NT; Fang, YL; Hsieh, PS; Huang, CJ; Huang, KT; Li, CC | 1 |
| Krishnan, N; Pandiyan, R; Velramar, B; Velu, RK | 1 |
| Al-Obaidi, H; Kalgudi, R; Zariwala, MG | 1 |
| Cannon, CL; Panzner, MJ; Shah, KN; Shah, PN; Smolen, JA; Tagaev, JA; Torrealba, J; Wagers, PO; Wooley, KL; Youngs, WJ; Zhang, F; Zhang, S; Zhou, L | 1 |
| Carrazco Rosales, JL; Chávez Morales, RM; Cruz, RV; Díaz Barriga Castro, E; Escárcega-González, CE; Garza-Cervantes, JA; Montelongo-Peralta, LZ; Morones-Ramírez, JR; Regalado Soto, DI; Saucedo-Salazar, EM; Treviño González, FM; Treviño-González, MT; Vázquez-Rodríguez, A | 1 |
| Biswas, P; Chakraborty, P; Joardar, S; Maiti, D; Ray, S; Tribedi, P | 1 |
| Chai, Y; Hu, Z; Xu, J; Zhang, J; Zhang, Y; Zhou, H | 1 |
| Cannon, CL; Chen, Q; Li, R; Sacchettini, JC; Salazar, AJ; Shah, KN; Shah, PN; Wooley, KL; Zhang, F | 1 |
| Davis, SC; Gil, J; Glinos, GD; Head, C; Higa, A; Li, J; Pastar, I; Solis, M; Valdes, J | 1 |
| Balasubramanian, P; Boccaccini, AR; Fiorilli, S; MacNeil, S; Paterson, TE; Shepherd, J; Stein, R; Vitale-Brovarone, C; Zheng, K | 1 |
| Badawy, HT; Brantner, JS; Clemons, C; Kreider, KL; Miller, JK; Milsted, A; Wagers, PO; Wilber, P; Young, G; Youngs, WJ; Yun, YH | 1 |
| Mewada, A; Oza, G; Pandey, S; Shah, R; Sharon, M; Thakur, M | 1 |
| Amirulhusni, AN; Durairaj, R; Ferina, N; Hussaini, J; Mohd-Zain, Z; Palanisamy, NK; Ping, LJ | 1 |
| Chen, J; Li, X; Wu, X; Zhao, Y; Zughaier, SM | 1 |
| Bae, MS; Heo, DN; Kim, EC; Kim, JE; Ko, WK; Kwon, IK; Lee, CH; Lee, DH; Lee, JB; Lee, SJ; Moon, JH; Park, SW | 1 |
| Bamford, A; Bishop, JRB; Burt, R; Fraise, AP; Halstead, FD; Moiemen, NS; Oppenheim, BA; Rauf, M; Wearn, CM; Webber, MA | 1 |
| Bharadwaj, R; Kumar, V; Mapara, N; Mohite, KC; Sharma, M; Shriram, V | 1 |
| Branquinha, MH; Devereux, M; Galdino, AC; Kellett, A; McCann, M; Nunes, AP; Santos, AL; Santos, KR; Viganor, L | 1 |
| Abou-Aisha, K; El-Azizi, M; El-Tayeb, TA; Nour El Din, S | 1 |
| Britland, ST; Gupta, A; Low, WL; Martin, C; Mohd Amin, MC; Radecka, I | 1 |
| Ali, SG; Ansari, MA; Cameotra, SS; Jalal, M; Khan, HM; Mahdi, AA | 1 |
| Ashraf, C; Breed, SM; Cardinale, JA; Coughlan, A; Hall, MM; Towler, MR | 1 |
| Ko, TH; Lin, JH; Lin, YH; Tseng, GC; Wang, SH | 1 |
| Balazs, DJ; Chevolot, Y; Harms, H; Hollenstein, C; Mathieu, HJ; Triandafillu, K; van Delden, C; Wood, P | 1 |
| Chu, CS; Mason, AD; McManus, AT; Pruitt, BA | 2 |
| Fox, CL; Modak, SM | 1 |
| Fox, CL; Fox, P; Friedlaender, J; Modak, S; Stanford, J | 1 |
| Jahns, T; Jansen, B; Rinck, M; Strohmeier, A; Wolbring, P | 1 |
| Ahearn, DG; Gabriel, MM; May, LL; Mayo, MS; Simmons, RB | 1 |
| Delank, KW; Nieschalk, M; Schmäl, F; Stoll, W | 1 |
| Drake, DJ; Froese, EH | 1 |
| Wysor, MS | 1 |
| Catania, PN; King, JC | 1 |
| Bertram, E; Köhnlein, HE; Springorum, HW; Winckler, S | 1 |
| Fox, CL; Modak, SM; Stanford, JW | 1 |
| Blagitko, EM; Ostashevskiĭ, AT; Vitsyn, BA | 1 |
| Chhibber, S; Saxena, M; Vasishta, R | 1 |
| Matusow, RJ | 1 |
| Albright, JA; Deitch, EA; Malakanok, V; Marino, AA | 1 |
| Fader, RC; Linares, HA | 1 |
| Bull, JP; Cason, JS; Davies, JW; Ford, PM; Jackson, DM; Lilly, HA; Lowbury, EJ | 1 |
| Wysor, MS; Zollinhofer, RE | 1 |
| Krizek, TJ; Robson, MC; Schaerf, RH | 1 |
| Groskin, MG; Krizek, TJ; Robson, MC | 1 |
| Fox, CL; Shimizu, Y; Tokumaru, T | 1 |
| McDougall, IA | 1 |
| Henry, RL; Nalbandian, RM; Wilks, HS | 1 |
| Fox, CL; Sampath, AC; Stanford, JW | 1 |
| Cossman, DV; Krizek, TJ | 1 |
| Fox, CL | 1 |
| Fox, CL; Rappole, BW; Stanford, W | 2 |
1 review(s) available for silver and Pseudomonas Infections
| Article | Year |
|---|---|
Acetic acid dressings used to treat pseudomonas colonised burn wounds: A UK national survey.
Topics: Acetic Acid; Anti-Infective Agents; Bandages; Burns; Humans; Pseudomonas; Pseudomonas Infections; Silver; Sodium Hypochlorite; Soft Tissue Injuries; State Medicine; United Kingdom; Wound Infection | 2022 |
1 trial(s) available for silver and Pseudomonas Infections
| Article | Year |
|---|---|
Alternative forms of local treatment for burns.
Topics: Acetates; Adolescent; Adult; Aged; Air; Body Temperature; Burns; Child; Child, Preschool; Enterobacteriaceae; Hot Temperature; Humans; Humidity; Infant; Infant, Newborn; Middle Aged; Ointments; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Silver; Silver Nitrate; Staphylococcal Infections; Staphylococcus; Sulfadiazine; Sulfonamides; Time Factors; Toluene; Wound Infection | 1971 |
66 other study(ies) available for silver and Pseudomonas Infections
| Article | Year |
|---|---|
Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
Topics: Alginates; Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Drug Carriers; Drug Design; Drug Therapy, Combination; Ferric Compounds; Humans; Magnetic Fields; Magnetite Nanoparticles; Microbial Sensitivity Tests; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Surface Properties; Tobramycin | 2020 |
The ability of a colloidal silver gel wound dressing to kill bacteria in vitro and in vivo.
Topics: Acinetobacter baumannii; Animals; Anti-Infective Agents, Local; Bandages; Biofilms; Disease Models, Animal; Gels; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2017 |
Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
Topics: Anti-Bacterial Agents; Apocynaceae; Biofilms; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Gentamicins; Green Chemistry Technology; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Particle Size; Phytochemicals; Plant Extracts; Plant Leaves; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim; Urinary Catheters; Urinary Tract Infections | 2021 |
Curcumin-Chitosan Nanocomposite Formulation Containing
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biocompatible Materials; Cell Line, Tumor; Chitosan; Curcumin; Humans; Metal Nanoparticles; Millettia; Nanocomposites; Nanotechnology; Particle Size; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Wound Healing | 2021 |
Biologically synthesized silver nanoparticles as potent antibacterial effective against multidrug-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Silver | 2022 |
Codelivery of synergistic antimicrobials with polyelectrolyte nanocomplexes to treat bacterial biofilms and lung infections.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Drug Carriers; Lung; Metal Nanoparticles; Mice; Microbial Sensitivity Tests; Pneumonia; Polyelectrolytes; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2023 |
Molecular detection of multidrug-resistant Pseudomonas aeruginosa of different avian sources with pathogenicity testing and in vitro evaluation of antibacterial efficacy of silver nanoparticles against multidrug-resistant P. aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Chick Embryo; Chickens; Drug Resistance, Multiple, Bacterial; Metal Nanoparticles; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Virulence | 2023 |
Biogenic silver nanoparticles as a more efficient contrivance for wound healing acceleration than common antiseptic medicine.
Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Metal Nanoparticles; Nanomedicine; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Wound Healing; Wound Infection; Wounds and Injuries | 2019 |
Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Burns; Graphite; Humans; Metals, Heavy; Microbial Sensitivity Tests; Plankton; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2020 |
Delivery of antibacterial silver nanoclusters to
Topics: Animals; Anti-Bacterial Agents; Aptamers, Nucleotide; Humans; Microbial Sensitivity Tests; Moths; Nanostructures; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2020 |
Antibacterial activity of biogenic silver and gold nanoparticles synthesized from Salvia africana-lutea and Sutherlandia frutescens.
Topics: Anti-Bacterial Agents; Gold; Green Chemistry Technology; Humans; Metal Nanoparticles; Particle Size; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Salvia; Silver; Staphylococcal Infections; Staphylococcus epidermidis | 2020 |
Sodium Salicylate Influences the
Topics: Anti-Bacterial Agents; Biofilms; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Silver; Sodium Salicylate; Virulence Factors | 2021 |
Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (blaNDM, blaVIM, blaOXA) producing clinically isolated Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Levofloxacin; Metal Nanoparticles; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2021 |
Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Corchorus; Drug Resistance, Multiple, Bacterial; Fibroblasts; Materials Testing; Metal Nanoparticles; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Particle Size; Plant Extracts; Plant Leaves; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcal Infections; Staphylococcus aureus; Surface Plasmon Resonance; Surgical Wound; X-Ray Diffraction | 2017 |
Non-sticky and antimicrobial zwitterionic nanocomposite dressings for infected chronic wounds.
Topics: Acrylic Resins; Animals; Anti-Infective Agents; Bandages; Male; Metal Nanoparticles; Nanocomposites; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Silver; Staphylococcal Infections; Staphylococcus epidermidis; Wound Healing | 2017 |
Anti-pseudomonal and anti-endotoxic effects of surfactin-stabilized biogenic silver nanocubes ameliorated wound repair in streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Bacterial Agents; Diabetes Mellitus, Experimental; Endotoxemia; Male; Metal Nanoparticles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Wound Infection | 2018 |
Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Biofilms; Chemical Engineering; Ciprofloxacin; Cystic Fibrosis; Drug Compounding; Drug Synergism; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Silicon Dioxide; Silver | 2018 |
A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bronchi; Cells, Cultured; Disease Models, Animal; Humans; In Vitro Techniques; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2018 |
In vivo antimicrobial activity of silver nanoparticles produced via a green chemistry synthesis using
Topics: Acacia; Animals; Anti-Infective Agents; Bacillus subtilis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Green Chemistry Technology; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Rats, Wistar; Silver; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared | 2018 |
3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
Topics: Anti-Bacterial Agents; Biofilms; Metal Nanoparticles; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Silver; Virulence Factors | 2018 |
Nano-silver modified porcine small intestinal submucosa for the treatment of infected partial-thickness burn wounds.
Topics: Animals; Anti-Infective Agents, Local; Biological Dressings; Burns; C-Reactive Protein; Disease Models, Animal; Inflammation; Interleukin-6; Jejunum; Male; Metal Nanoparticles; Neovascularization, Physiologic; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Re-Epithelialization; Silver; Swine; Wound Healing; Wound Infection | 2019 |
Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Metal Nanoparticles; Minocycline; Polyphosphates; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2019 |
Preclinical evaluation of a novel silver gelling fiber dressing on Pseudomonas aeruginosa in a porcine wound infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Physiological Phenomena; Bandages, Hydrocolloid; Biofilms; Disease Models, Animal; Female; Gels; Pseudomonas Infections; Silver; Swine; Wound Healing; Wound Infection | 2019 |
Ag modified mesoporous bioactive glass nanoparticles for enhanced antibacterial activity in 3D infected skin model.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Glass; Humans; Mice; Models, Biological; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Skin; Staphylococcal Skin Infections; Staphylococcus aureus | 2019 |
Mathematical modelling of Pseudomonas aeruginosa biofilm growth and treatment in the cystic fibrosis lung.
Topics: Biofilms; Computer Simulation; Cystic Fibrosis; Humans; In Vitro Techniques; Microscopy, Confocal; Models, Immunological; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sputum | 2014 |
Understanding the stability of silver nanoparticles bio-fabricated using Acacia arabica (Babool gum) and its hostile effect on microorganisms.
Topics: Acacia; Anti-Bacterial Agents; Bacillus subtilis; Green Chemistry Technology; Gum Arabic; Humans; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Reducing Agents; Silver | 2013 |
Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Metal Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2014 |
Culture-free diagnostics of Pseudomonas aeruginosa infection by silver nanorod array based SERS from clinical sputum samples.
Topics: Humans; Nanotubes; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sputum | 2014 |
Electrospun chitosan nanofibers with controlled levels of silver nanoparticles. Preparation, characterization and antibacterial activity.
Topics: Anti-Bacterial Agents; Bandages; Chitosan; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Nanofibers; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.
Topics: Acetic Acid; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bandages; Biofilms; Burns; Chlorhexidine; Honey; In Vitro Techniques; Iodine; Microbial Sensitivity Tests; Polyesters; Polyethylenes; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Wound Infection | 2015 |
Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Humans; Malvaceae; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanoparticles; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Spectrum Analysis | 2015 |
Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
Topics: Anti-Bacterial Agents; Biofilms; Brazil; Copper; Humans; Microbial Sensitivity Tests; Phenanthrolines; Pseudomonas aeruginosa; Pseudomonas Infections; Silver | 2016 |
In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Horses; Light; Metal Nanoparticles; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Silver | 2016 |
Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels.
Topics: Anti-Bacterial Agents; Bandages, Hydrocolloid; Cellulose; Drug Delivery Systems; Gluconacetobacter xylinus; Hydrogels; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2016 |
Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Capparaceae; Drug Resistance, Multiple, Bacterial; Hemolysin Proteins; Metal Nanoparticles; Microscopy, Confocal; Microscopy, Electron, Transmission; Pentacyclic Triterpenes; Plant Extracts; Plants, Medicinal; Proteolysis; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Quorum Sensing; Silver; Virulence Factors | 2017 |
Does elevating silver content in zinc-based glass polyalkenoate cements increase their antibacterial efficacy against two common bacteria using the agar gel diffusion method?
Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Glass Ionomer Cements; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Staphylococcal Infections; Staphylococcus aureus; Zinc | 2013 |
Evaluation of silver-containing activated carbon fiber for wound healing study: In vitro and in vivo.
Topics: Animals; Anti-Infective Agents, Local; Bandages; Carbon; Carbon Fiber; Cell Survival; Cells, Cultured; Drug Resistance, Multiple, Bacterial; Fibroblasts; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Silver; Wound Healing; Wound Infection | 2012 |
Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments.
Topics: Bacterial Adhesion; Biofilms; Cell Division; Coated Materials, Biocompatible; Cross Infection; Equipment Contamination; Equipment Failure Analysis; Hot Temperature; Humans; Intubation, Intratracheal; Polyvinyl Chloride; Pseudomonas; Pseudomonas Infections; Radio Waves; Silver; Sodium Hydroxide; Surface Properties | 2004 |
Topical silver treatment after escharectomy of infected full thickness burn wounds in rats.
Topics: Abscess; Administration, Topical; Animals; Burns; Debridement; Disease Models, Animal; Male; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Silver; Survival Analysis; Treatment Outcome; Wound Infection | 2005 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mice; Nalidixic Acid; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Salts; Silver; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1981 |
Control of burn wound infections by pefloxacin and its silver derivative.
Topics: Administration, Topical; Animals; Body Weight; Burns; Female; Mice; Nalidixic Acid; Pefloxacin; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Time Factors; Tissue Distribution | 1984 |
In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter.
Topics: Animals; Bacteria; Bacterial Adhesion; Bacterial Physiological Phenomena; Biocompatible Materials; Blood; Catheterization, Central Venous; Cells, Cultured; Equipment Contamination; Equipment Design; Escherichia coli; Escherichia coli Infections; Evaluation Studies as Topic; Fibroblasts; Materials Testing; Mice; Polyurethanes; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Silver; Staphylococcal Infections; Staphylococcus epidermidis; Surface Properties | 1994 |
In vitro evaluation of the efficacy of a silver-coated catheter.
Topics: Bacterial Adhesion; Escherichia coli Infections; Evaluation Studies as Topic; Humans; In Vitro Techniques; Latex; Microscopy, Electron, Scanning; Pseudomonas Infections; Silicones; Silver; Urinary Catheterization; Urinary Tract Infections | 1996 |
[Infection frequency and type of bacteria after tympanostomy tube drainage in childhood: gilded-silver tubes versus silicone tubes].
Topics: Bacteria; Child, Preschool; Equipment Contamination; Female; Gold; Humans; Incidence; Male; Mastoid; Mastoiditis; Middle Ear Ventilation; Otitis Media; Postoperative Complications; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Silicones; Silver; Staphylococcal Infections; Staphylococcus aureus | 1999 |
The preparation and invivo use of silver sulphadiazine cream for treatment of burns infected with Pseudomonas aeruginosa.
Topics: Burns; Humans; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine; Wound Infection | 1975 |
Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
Topics: Administration, Oral; Animals; Injections, Subcutaneous; Malaria; Mice; Mice, Inbred Strains; Plasmodium berghei; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine | 1975 |
Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
Topics: Animals; Burns; Guinea Pigs; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Sulfadiazine; Time Factors | 1975 |
[The local effect of a silver chelate on standardized scald wounds of the rat].
Topics: Animals; Burns; Chelating Agents; Female; Gels; Gentamicins; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver | 1975 |
Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
Topics: Administration, Topical; Animals; Blood Proteins; Burns; DNA; Eating; Lethal Dose 50; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Sulfadiazine; Wound Healing; Zinc | 1976 |
[Treatment of postoperative septicemia by intravenous administration of ammonia solutions of silver].
Topics: Adult; Ammonia; Humans; Injections, Intravenous; Male; Pseudomonas Infections; Sepsis; Silver; Solutions; Staphylococcal Infections; Surgical Wound Infection | 1976 |
Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis.
Topics: Animals; Burns; Disease Models, Animal; Drug Resistance, Microbial; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Virulence; Wound Infection | 1991 |
Acute pulpal-alveolar cellulitis syndrome. IV. Exacerbations during endodontic treatment. Part 3. A case report.
Topics: Abscess; Bicuspid; Cellulitis; Humans; Male; Middle Aged; Oxidation-Reduction; Periapical Periodontitis; Pseudomonas Infections; Pulpitis; Root Canal Filling Materials; Root Canal Therapy; Silver; Streptococcal Infections; Syndrome; Tooth Diseases | 1988 |
Therapeutic effects of silver nylon dressings with weak direct current on Pseudomonas aeruginosa-infected burn wounds.
Topics: Animals; Bandages; Burns; Electricity; Male; Nylons; Pseudomonas Infections; Rats; Rats, Inbred Strains; Silver; Silver Sulfadiazine; Wound Infection | 1988 |
Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity.
Topics: Bandages; Biological Dressings; Burns; Clostridium Infections; Nylons; Pseudomonas Infections; Silver; Staphylococcal Infections | 1987 |
Evaluation of topical therapy with silver-kaolin (Argostop) in an experimental model of burn wound sepsis.
Topics: Administration, Topical; Animals; Burns; Disease Models, Animal; Drug Combinations; Kaolin; Male; Pseudomonas Infections; Rats; Rats, Inbred Strains; Silver; Wound Healing; Wound Infection | 1987 |
Silver phosphanilamidopyrimidine. A new silver sulfadiazine analogue effective against Pseudomonas infection in burned mice.
Topics: Animals; Burns; Culture Media; Culture Techniques; Female; Mice; Ointments; Organophosphorus Compounds; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines; Silver; Time Factors | 1973 |
Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
Topics: Animals; Autopsy; Biopsy; Burns; Evaluation Studies as Topic; Liver; Lung; Male; Povidone; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Spleen; Sulfadiazine; Sulfonamides; Time Factors; Tosyl Compounds; Virulence; Wound Infection | 1974 |
Experimental burn wound sepsis--evaluation of enzymatic debridement.
Topics: Animals; Bacillus subtilis; Burns; Debridement; Drug Evaluation; Drug Therapy, Combination; Endopeptidases; Male; Methods; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Subtilisins; Sulfadiazine; Sulfonamides; Swine; Tosyl Compounds; Virulence; Wound Infection | 1974 |
Antiviral activities of silver sulfadiazine in ocular infection.
Topics: Animals; Antiviral Agents; Cell Line; Cornea; Cricetinae; DNA; Eye Diseases; Humans; Keratitis, Dendritic; Kidney; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Silver; Simplexvirus; Sulfadiazine; Thymidine; Tritium; Vesicular stomatitis Indiana virus; Virus Diseases; Virus Replication | 1974 |
Use of silver sulphadiazine in the treatment of burns at Royal Perth Hospital.
Topics: Adult; Burns; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Silver; Skin Transplantation; Sulfadiazine; Transplantation, Autologous | 1972 |
Artificial skin. II. Pluronic F-127 Silver nitrate or silver lactate gel in the treatment of thermal burns.
Topics: Animals; Burns; Gels; Glycols; Lactates; Male; Polymers; Proteus Infections; Pseudomonas Infections; Rats; Silver; Silver Nitrate; Skin; Surface-Active Agents; Wound Healing; Wound Infection | 1972 |
Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide.
Topics: Animals; Burns; Culture Techniques; Heart; Mice; Ointments; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Silver; Species Specificity; Sulfadiazine; Sulfonamides; Toluene; Virulence | 1970 |
Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
Topics: Allantoin; Animals; Burns; Lactates; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Silver; Skin; Sulfadiazine; Sulfonamides; Wound Infection | 1971 |
Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.
Topics: Aminobenzoates; Animals; Anti-Infective Agents, Local; Burns; Humans; Mice; Nitrobenzenes; Ointments; Pseudomonas Infections; Silver; Silver Nitrate; Sodium Chloride; Sulfadiazine; Sulfonamides | 1968 |
Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
Topics: Adult; Animals; Anti-Infective Agents, Local; Burns; Child; Female; Humans; Male; Mice; Military Medicine; Pseudomonas Infections; Silver; Skin Diseases, Infectious; Sulfadiazine | 1969 |
Control of pseudomonas infection in burns by silver sulfadiazine.
Topics: Adult; Animals; Burns; Cephalothin; DNA; DNA, Bacterial; Female; Guinea Pigs; Humans; Mice; Military Medicine; New York; Ointments; Protein Binding; Pseudomonas Infections; Silver; Sulfadiazine; Vietnam | 1969 |